Review Objective The objective of this review is to synthesize the best available evidence on the effectiveness of individualised survivor care plans as compared to usual care on quality of life for adult female breast cancer survivors. Types of participants This review will consider studies that include adult female breast cancer survivors, 18 years of age or older. A breast cancer survivor will be defined as one who has completed treatment for breast cancer and are considered cured, but who continue to experience the emotional and physical impact of the disease7. The concept of survivorship and quality of life will cover the physical, psychosocial, and sexual issues of cancer. Types of intervention/phenomena of interest This review will consider individualised survivorship care plans as the additional intervention provided to adult female with breast cancer survivors receiving the standard or routine care. The comparator: usual care. Usual care is standard or routine care for adult female breast cancer survivors. Outcome measures This review will consider studies that include the following outcome measures: survivor’s quality of life as it relates to physical, psychosocial, and sexual health. These outcome measures are critical components of survivorship care plans. Studies will be reviewed for evidence of standardised valid and reliable tools measuring quality of life in breast cancer survivors, such as the Long Term Quality of Life Breast Cancer (LTQOL-BC) scale36 and the Cancer Rehabilitation Evaluation System-Short Form (CARES-SF)37. The LTQOL-BC measures seven domains which include physical, sexual and cognitive function, body image, coping, social support, and anxiety. The CARES-SF instrument assesses the rehabilitative and quality of life needs of cancer patients. The tool is a questionnaire with five sub-scales measuring quality of life domains that include physical, psychosocial, medical interaction, marital, and sexual. Other tools identified in the studies will be appraised for their reliability and validity.